SCHEMBL146124

SCHEMBL146124

O=C1NCCN1N1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851485 0.86 KDM4E (0.30)
SCHEMBL5904175 0.75 CRBN (0.37)
SCHEMBL1971796 0.74 CDA (0.33)
SCHEMBL306969 0.73 KDM4E (0.34)
SCHEMBL27755656 0.71 BRD4 (0.35)
SCHEMBL4500931 0.70 GAA (0.35)
SCHEMBL10772828 0.70
SCHEMBL28410669 0.69
SCHEMBL232289 0.69
SCHEMBL8875695 0.68 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12006331-B2 Therapeutic compounds and methods GENENTECH, INC. (US) 2024-06-11 US disclosed
EP-4370130-A1 THERAPEUTIC COMPOUNDS AND METHODS Genentech, Inc. (US) 2024-05-22 EP disclosed
US-11987572-B2 Therapeutic compounds and methods of use thereof REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-05-21 US disclosed
EP-4362985-A1 OLIGONUCLEOTIDE CONJUGATES TARGETED TO THE TRANSFERRIN RECEPTOR Denali Therapeutics Inc. (US) 2024-05-08 EP disclosed
WO-2024086161-A2 EPHA2 TARGETING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-04-25 WO disclosed
US-20240109872-A1 CONTRACEPTIVE COMPOUNDS AND METHODS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-04-04 US disclosed
CN-117693367-A Oligonucleotide conjugates targeting transferrin receptor 戴纳立制药公司 2024-03-12 CN disclosed
CN-117642170-A Therapeutic compounds and methods 基因泰克公司 2024-03-01 CN disclosed
WO-2024044375-A2 ANTIVIRAL COMPOUNDS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-02-29 WO disclosed
US-20240051938-A1 SELECTIVE BRD4-DEGRADER MOLECULES REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2024-02-15 US disclosed
US-20200255454-A1 SEPARATIONS USING BORON CONTAINING HYDROCARBON SPONGES UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2020-08-13 US disclosed
WO-2019240884-A9 COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2020-02-06 WO disclosed
WO-2019046465-A2 THERAPEUTIC INDOLES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2019-03-07 WO disclosed
US-20180360972-A1 THERAPEUTIC COMPOUNDS REGENTS OF THE UNIVERSITY OF MINNESOTA 2018-12-20 US disclosed
US-20180339972-A1 LACTONE-BASED PROBES AND METHODS OF USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2018-11-29 US disclosed
US-20180292387-A1 ANTIBIOTIC-BASED CONJUGATES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-10-11 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
EP-1289984-A4 NOVEL OXAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF DONG A PHARM CO LTD (KR) 2004-11-24 EP disclosed
EP-1289984-A1 NOVEL OXAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF Dong A Pharmaceutical Co. Ltd. (KR) 2003-03-12 EP disclosed
WO-2001094342-A1 NOVEL OXAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF DONG A PHARM. CO., LTD. (KR) 2001-12-13 WO disclosed